Cathepsin D has also been observed in numerous cancers, including gliomas, with significantly elevated levels of expression in more aggressive gliomas, such as GBM, implying that serum cathepsin D levels could be a prognostic marker for GBM (37). The gene discussed is CTSD; the disease is central nervous system cancer.